America Great Health
Healthcare · Pharmaceutical Preparations · CA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $391,743 | $294,670 | $204,308 | $104,648 | $195,671 | $5,474 |
| Operating income | −$382,935 | −$782,700 | −$492,644 | −$4.7M | −$243,560 | −$46,151 |
| Net income | −$719,119 | −$1.2M | −$761,420 | −$4.9M | −$269,054 | −$51,916 |
| Total assets | $301,817 | $323,478 | $299,129 | $336,143 | $623,018 | $3,894 |
| Total liabilities | $6.0M | $5.4M | $4.7M | $4.2M | $1.1M | $218,901 |
| Equity | −$5.7M | −$5.0M | −$4.3M | −$3.8M | −$467,827 | −$215,007 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | — | — | — |
| Shares out. | 21.15B | 21.19B | 21.11B | 21.09B | 21.08B | 20.24B |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −97.8%
- Net margin
- −183.6%
- Return on equity
- 12.7%
- Return on assets
- −238.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 2003.1%
- Debt / equity
- —
- Book value / share
- $-0.00
- Revenue growth (YoY)
- 32.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -203.86distress
- Accruals / assets
- −128.0%clean
- Beneish M-Score
- -9.40normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 29, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Kmissed a reporting deadline ↗Sep 30, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Qmissed a reporting deadline ↗Feb 12, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 1, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer changeSep 15, 2025
- Entered a material agreementOct 25, 2024
- Entered a material agreementOct 18, 2024
- Entered a material agreementOct 9, 2024
- Entered a material agreementOct 4, 2024
- Entered a material agreementOct 2, 2024
- Entered a material agreementSep 26, 2024
- Entered a material agreementSep 17, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-KFORM 10-KApr 10, 2026
- NT 10-KFORM NT 10-KSep 29, 2025
- 8-KFORM 8-KSep 15, 2025
- 10-QFORM 10-QMay 15, 2025
- 10-QFORM 10-QApr 14, 2025
- 10-QFORM 10-QMar 27, 2025
- 10-KFORM 10-KFeb 25, 2025
- NT 10-QFORM NT 10-QNov 15, 2024
- 8-KFORM 8-KOct 25, 2024
- 8-KFORM 8-KOct 18, 2024
- 8-KFORM 8-KOct 9, 2024
- 8-KFORM 8-KOct 4, 2024
- 8-KFORM 8-KOct 2, 2024
- NT 10-KFORM NT 10-KSep 30, 2024
- 8-KFORM 8-KSep 26, 2024